Company registration number 08756451 (England and Wales)
NORTHERN HEALTH SCIENCE ALLIANCE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
NORTHERN HEALTH SCIENCE ALLIANCE LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
NORTHERN HEALTH SCIENCE ALLIANCE LTD
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
136,547
386,058
Cash at bank and in hand
765,531
862,081
902,078
1,248,139
Creditors: amounts falling due within one year
4
(476,055)
(539,583)
Net current assets
426,023
708,556
Reserves
Income and expenditure account
426,023
708,556
Total members' funds
426,023
708,556

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income and expenditure account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 2 June 2026 and are signed on its behalf by:
H Davies
Director
Company registration number 08756451 (England and Wales)
NORTHERN HEALTH SCIENCE ALLIANCE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true

1.3
Income and expenditure

Income and expenses are included in the financial statements as they become receivable or due.

Expenses include VAT where applicable as the company cannot reclaim it.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Taxation

The company is exempt from corporation tax on its grant and members' subscriptions,

as the company deems that it is not carrying on a business for the purposes of making a profit.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Government grants

Grants are recognised based on the accrual model. Grants are recognised in income over the period in which the related costs are recognised. Where amounts are received in advance, these are recorded as deferred income. The grants are provided by the UK government on the basis that they will be allocated to organisations for the purpose of medical research.

NORTHERN HEALTH SCIENCE ALLIANCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.10
Company information

Northern Health Science Alliance Ltd is a private company limited by guarantee incorporated in England and Wales. The registered office is Hardman Square, No 1 Spinningfields, Manchester, M3 3EB.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
16
16
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Service charges due
134,999
379,311
Other debtors
1,548
6,747
136,547
386,058
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
69,733
94,794
Other creditors
406,322
444,789
476,055
539,583

There is a fixed and floating charge on the Company's assets.

5
Members' liability

The company is limited by guarantee and has no share capital. Consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up such amounts as may be required not exceeding £1.

2025-09-30 2024-10-01 false false false 03 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Professor L C Kenny Dr K P Mackay J P Sheffield P Wood H Davies Professor M Kearney Dr K L Wood 08756451 2024-10-01 2025-09-30 08756451 2025-09-30 08756451 2024-09-30 08756451 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 08756451 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 08756451 core:WithinOneYear 2025-09-30 08756451 core:WithinOneYear 2024-09-30 08756451 core:CurrentFinancialInstruments 2025-09-30 08756451 core:CurrentFinancialInstruments 2024-09-30 08756451 core:RetainedEarningsAccumulatedLosses 2025-09-30 08756451 core:RetainedEarningsAccumulatedLosses 2024-09-30 08756451 bus:Director5 2024-10-01 2025-09-30 08756451 2023-10-01 2024-09-30 08756451 bus:CompanyLimitedByGuarantee 2024-10-01 2025-09-30 08756451 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 08756451 bus:FRS102 2024-10-01 2025-09-30 08756451 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 08756451 bus:Director1 2024-10-01 2025-09-30 08756451 bus:Director2 2024-10-01 2025-09-30 08756451 bus:Director3 2024-10-01 2025-09-30 08756451 bus:Director4 2024-10-01 2025-09-30 08756451 bus:Director6 2024-10-01 2025-09-30 08756451 bus:Director7 2024-10-01 2025-09-30 08756451 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP